What is the treatment for group B strep (Streptococcus agalactiae) colonization during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group B Streptococcus During Pregnancy

Pregnant women with Group B Streptococcus (GBS) colonization should receive intrapartum antibiotic prophylaxis with intravenous penicillin G (5 million units IV initial dose, followed by 2.5 million units IV every 4 hours until delivery) to prevent early-onset neonatal GBS disease. 1

Screening and Identification

  • All pregnant women should be screened for GBS colonization at 35-37 weeks' gestation with vaginal-rectal cultures 2
  • Screening involves collection of a single swab or two separate swabs from the distal vagina and rectum (not by speculum examination) 2
  • Specimens should be placed in transport medium if the laboratory is offsite and specifically identified for GBS culture 2

Indications for Intrapartum Antibiotic Prophylaxis

Intrapartum antibiotic prophylaxis is indicated in the following situations:

  • Positive GBS vaginal-rectal screening culture in current pregnancy 2, 1
  • GBS bacteriuria during any trimester of current pregnancy 2, 1
  • Previous infant with invasive GBS disease 2, 1
  • Unknown GBS status at labor onset with any of the following risk factors:
    • Delivery at <37 weeks' gestation
    • Amniotic membrane rupture ≥18 hours
    • Intrapartum temperature ≥100.4°F (≥38.0°C) 2

Antibiotic Regimens

First-line therapy:

  • Penicillin G: 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery 2, 1

Alternative regimens:

  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 2, 1
    • Note: Penicillin G is preferred due to its narrower spectrum 2

For penicillin-allergic women:

  • Non-anaphylactic allergy: Cefazolin 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1
  • Anaphylactic allergy: Clindamycin (if isolate is susceptible) 2, 1
    • Note: Erythromycin is no longer recommended due to increasing resistance and poor placental transfer 1

Important Considerations

  • Intrapartum antibiotics should be administered as early as possible during labor for maximum effectiveness, ideally at least 4 hours before delivery 1, 3
  • Oral antibiotics during pregnancy are NOT effective for eliminating GBS colonization or preventing neonatal disease 2, 1
  • Treatment of GBS bacteriuria during pregnancy should follow standard UTI treatment protocols, but intrapartum prophylaxis is still required during labor 1
  • Intrapartum antibiotic prophylaxis is not indicated for cesarean delivery performed before labor onset on a woman with intact amniotic membranes, regardless of GBS status 2

Effectiveness and Safety

  • Intrapartum antibiotic prophylaxis reduces the risk of early-onset neonatal GBS infection from approximately 4.7% to 0.4% 4
  • The main risk of penicillin therapy is anaphylactic reaction (approximately 5 cases per 10,000 treatments) 4
  • Implementation of GBS screening and prophylaxis guidelines has been associated with significant decline in early-onset neonatal GBS infections 4

Following these evidence-based guidelines for GBS screening and prophylaxis is crucial for preventing early-onset neonatal GBS disease, which remains a significant cause of neonatal morbidity and mortality.

References

Guideline

Group B Streptococcus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.